A Study to Assess the Efficacy of Public Health Campaigns in Reducing Lead Exposure
This clinical trial aims to evaluate the effectiveness of targeted public health campaigns in reducing lead exposure among adults living in urban communities with known environmental lead hazards. Lead exposure remains a significant public health concern, particularly in older urban neighborhoods with aging infrastructure and legacy contamination. Despite existing regulations and remediation efforts, many communities continue to experience elevated blood lead levels, especially among vulnerable populations.
The study will compare the impact of an intensive, multi-modal public health campaign-featuring community workshops, educational materials, and home intervention resources-against standard municipal information dissemination. By assessing changes in blood lead levels and lead-related knowledge, attitudes, and behaviors over a 12-month period, the trial seeks to determine whether enhanced public health outreach can more effectively reduce lead exposure and promote safer practices. The findings will inform future strategies for community-based environmental health interventions.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Lead exposure is a persistent environmental health issue, particularly in urban areas with older housing stock, deteriorating paint, and legacy industrial contamination. Chronic lead exposure, even at low levels, has been associated with neurodevelopmental deficits in children and cardiovascular, renal, and cognitive effects in adults. Despite regulatory progress, disparities in lead exposure persist, often affecting low-income and minority communities.
Traditional public health approaches have relied on passive dissemination of information via municipal websites, pamphlets, and occasional community events. However, evidence suggests that more intensive, community-engaged interventions may be necessary to change behaviors and reduce environmental risks. This study is designed to rigorously assess the efficacy of a comprehensive public health campaign compared to standard information dissemination in reducing lead exposure.
The trial will enroll households from urban neighborhoods identified through environmental surveillance as having elevated lead risks. Eligible participants will be randomized to either the intensive campaign arm or the standard information arm. The intensive campaign will include a series of interactive community workshops, distribution of tailored educational materials, provision of lead-safe cleaning kits, and access to home visits by trained health educators. The control group will receive the standard municipal information package currently in use.
Primary outcomes will include changes in blood lead levels among index participants at baseline and after 12 months. Secondary outcomes will assess changes in lead-related knowledge, adoption of lead-safe practices, and environmental lead measurements in the home. The study will also monitor the incidence of new cases of elevated blood lead and assess participant satisfaction with the interventions.
Data will be collected through home visits, validated questionnaires, and laboratory testing. The trial will use a parallel-group, randomized controlled design with community-level randomization to minimize contamination. Results will inform policymakers and public health practitioners regarding the value of intensive, community-based approaches for environmental hazard reduction.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Brian Goldstein, MD MPH
- Telefoonnummer: 215-287-7688
- E-mail: Brian.Goldstein@intlhealthstrategies.com
Studie Locaties
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Verenigde Staten, 19107
- Philadelphia City Center
-
Contact:
- Brian Goldstein, MD MPH
- Telefoonnummer: 215-287-7688
- E-mail: brgold@sas.upenn.edu
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Resident of selected urban neighborhoods with documented environmental lead risk
- Household includes at least one adult aged 18-75 years willing to participate
- Willing to provide informed consent
- Willing to allow home visits and blood sampling
- Able to understand study procedures and interventions
Exclusion Criteria:
- Planning to relocate from the area within the next 12 months
- Household member with a known diagnosis of severe anemia or bleeding disorder
- Participation in another intervention study targeting lead exposure in the past 12 months
- Inability or unwillingness to comply with study procedures
- Household with known ongoing lead remediation efforts during the study period
- Pregnant women (due to additional ethical considerations for blood sampling)
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Intensive Public Health Campaign
Participants receive an intensive, multi-modal public health campaign including workshops, educational materials, lead-safe cleaning kits, and home visits by health educators.
|
A comprehensive intervention including: (1) three interactive community workshops on lead risks and prevention, (2) distribution of tailored educational materials, (3) provision of lead-safe cleaning kits (HEPA vacuums, cleaning supplies), and (4) two home visits by trained health educators to reinforce messages and assess household practices.
Delivered over a 12-month period.
|
|
Actieve vergelijker: Standard Information Dissemination
Participants receive the standard municipal information package on lead exposure prevention currently distributed by city health departments.
|
Provision of standard municipal information on lead exposure prevention, including pamphlets and website links, as currently distributed by public health authorities.
No additional workshops or home visits provided.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Blood Lead Level
Tijdsspanne: Through study completion, an average of 1 year
|
Mean change in venous blood lead concentration (μg/dL) among index household participants from baseline to 12 months.
|
Through study completion, an average of 1 year
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Lead-Related Knowledge
Tijdsspanne: Through study completion, an average of 1 year
|
Change in scores on a validated questionnaire assessing knowledge of lead exposure risks and prevention strategies.
|
Through study completion, an average of 1 year
|
|
Adoption of Lead-Safe Practices
Tijdsspanne: Through study completion, an average of 1 year
|
Proportion of households reporting regular use of lead-safe cleaning and food preparation practices, as assessed by structured survey.
|
Through study completion, an average of 1 year
|
|
Environmental Lead Levels in Home
Tijdsspanne: Through study completion, an average of 1 year
|
Change in environmental lead concentrations (surface dust, tap water) measured in the home.
|
Through study completion, an average of 1 year
|
|
Incidence of New Elevated Blood Lead Cases
Tijdsspanne: Through study completion, an average of 1 year
|
Number of new cases of blood lead ≥5 μg/dL among children and adults during the study period.
|
Through study completion, an average of 1 year
|
Medewerkers en onderzoekers
Onderzoekers
- Studie directeur: Brian Goldstein, MD MPH, International Health Strategies LLC
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- InternationalHealth2026
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .